Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 1 day ago Drug news

Post-hoc analysis of 3 phase III trials of Plenvu demonstrate high quality cleaning in bowel cleansing.- Norgine.

Norgine presented new data demonstrating the superior high-quality bowel cleansing efficacy (in at least one segment of the colon) of...

Added 19 days ago Drug news

Settlement of AbbVIe and Amgen litigation concerning Amgevita/Amjevita (adalimumab biosimilar).- Amgen

Amgen has announced that it has reached a global settlement with AbbVie to resolve all pending litigation regarding Amgevita/ Amjevita,...

Added 29 days ago Drug news

CHMP recommends Cyltezo (adalimumab biosimilar) to treat multiple chronic inflammatory diseases based on clinical equivalence to Humira (adalimumab), the reference product.- Boehringer.

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Search all news articles for Regional enteritis and ulcerative colitis
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

Visit Acute and Advanced Heart Failure

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 3 more

Visit Chronic Spontaneous Urticaria (CSU)

Guidelines

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

Trying to conceive and being pregnant is an emotional period for those involved. In the majority of patients suffering from...

Added 2 years ago

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

The goal of this consensus initiated by the European Crohn’s and Colitis Organisation [ECCO] was to establish European consensus guidelines...

Added 2 years ago

European evidence based consensus on surgery for ulcerative colitis

The goal of this consensus initiated by the European Crohn's and Colitis Organisation (ECCO) was to establish European consensus guidelines...

Added 2 years ago

Search all guidelines for Regional enteritis and ulcerative colitis
 

Journal articles

Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease.

Background: Vedolizumab specifically recognises the α4β7 integrin and selectively blocks gut lymphocyte trafficking: potentially, it offers gut-specific immunosuppression.

Added 21 days ago

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.

Ulcerative colitis (UC) is a chronic relapsing and remitting inflammatory bowel disease, with a characteristic leukocytic infiltration of the mucosa.

Added 21 days ago

A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab.

Vedolizumab is a humanized anti-α4β7 integrin monoclonal antibody that selectively blocks trafficking of memory T cells to inflamed gut tissue by inhibiting the α4β7-mucosal addressin cell adhesion molecule-1...

Added 21 days ago

Search all journal articles for Regional enteritis and ulcerative colitis